KHRNF - Khiron Life Sciences Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.90M
Enterprise Value 7.37M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.47
Price/Book (mrq)0.34
Enterprise Value/Revenue 0.46
Enterprise Value/EBITDA -0.26

Trading Information

Stock Price History

Beta (5Y Monthly) 3.15
52-Week Change 3-70.00%
S&P500 52-Week Change 31.77%
52 Week High 30.1680
52 Week Low 30.0120
50-Day Moving Average 30.0366
200-Day Moving Average 30.0648

Share Statistics

Avg Vol (3 month) 3254.01k
Avg Vol (10 day) 3218.26k
Shares Outstanding 5232.41M
Implied Shares Outstanding 6N/A
Float 8206.03M
% Held by Insiders 14.64%
% Held by Institutions 10.22%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022

Profitability

Profit Margin -190.00%
Operating Margin (ttm)-108.07%

Management Effectiveness

Return on Assets (ttm)-20.79%
Return on Equity (ttm)-74.68%

Income Statement

Revenue (ttm)16.14M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)-3.80%
Gross Profit (ttm)6.37M
EBITDA -16.41M
Net Income Avi to Common (ttm)-30.66M
Diluted EPS (ttm)-0.1100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.94M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.56M
Total Debt/Equity (mrq)9.46
Current Ratio (mrq)2.02
Book Value Per Share (mrq)0.12

Cash Flow Statement

Operating Cash Flow (ttm)-15.01M
Levered Free Cash Flow (ttm)-8.83M